(Q42273814)

English

Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy

scientific article published on 24 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Katharina Seeber

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Christoph Koidl

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Walter Buzina

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Albert Wölfler

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Wiebke Duettmann

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jasmin Wagner

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Volker Strenger

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Robert Krause

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

471-476

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Therapeutic drug monitoring of posaconazole in allogeneic hematopoietic stem cell transplantation patients who develop gastrointestinal graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Posaconazole treatment in hematology patients: a pilot study of therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FMYC.12060

21 January 2018

Identifiers

10.1111/MYC.12060

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42273814&oldid=1970200857"